Qiang Xu

机构：Nanjing Drum Tower Hospital · ORCID：0009-0003-3169-2919

发表论文 45 篇 · 总被引 1449 次 · h-index 19

代表论文

• Targeting SHP2 as a promising strategy for cancer immunotherapy (2019 · Pharmacological Research · 被引 172)
• Brain–computer interfaces: the innovative key to unlocking neurological conditions (2024 · International Journal of Surgery · 被引 156)
• Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways (2021 · Journal of Ethnopharmacology · 被引 30)
• Effects and mechanisms of natural plant active compounds for the treatment of osteoclast-mediated bone destructive diseases (2021 · Journal of drug targeting · 被引 27)
• Identification of m7G regulator-mediated RNA methylation modification patterns and related immune microenvironment regulation characteristics in heart failure (2023 · Clinical Epigenetics · 被引 18)
• Identification of hub genes and transcription factor regulatory network for heart failure using RNA-seq data and robust rank aggregation analysis (2022 · Frontiers in Cardiovascular Medicine · 被引 17)